Latest 10-Q quarterly reports
NASDAQ
Strive, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing significant net losses driven by unrealized losses on digital assets and increased operating expenses, alongside strategic capital raises and preferred stock dividends.
NYSE
JBG SMITH Properties filed its Q2 2026 10-Q, detailing a net loss attributable to common shareholders of $59.2 million, significant impairment charges, and a substantial legal judgment against the company.
AMEX
Westwater Resources, Inc. reported a wider net loss for the second quarter of 2026, driven by increased operating expenses and continued investment in its graphite projects, while highlighting progress in permitting and financing efforts.
NASDAQ
POWW
Ammo, INCOutdoor Holding Company (POWW) announced a substantial increase in net revenues and a return to profitability in Q1 2026, alongside the successful resolution of its SEC investigation without financial penalties.
OTC.Pink
TCRI
Techcom, INCTechCom, Inc. filed its Q2 2026 Form 10-Q, revealing no revenue, a continued lack of operations, and substantial doubt regarding its ability to continue as a going concern.
NYSE
DOLE
Dole PLCDole plc's Q2 2026 Form 10-Q filing shows a 2.9% increase in quarterly revenue to $2.5 billion, driven by diversified produce and favorable currency impacts, though cost of sales also rose.
NASDAQ
National Energy Services Reunited Corp. (NESR) announced a substantial increase in Q2 2026 revenue and net income, driven by strong performance in its Production Services and Drilling and Evaluation Services segments, particularly in Saudi Arabia.
OQB
Blue Biofuels, Inc. reported zero revenue for the quarter ended June 30, 2026, with a substantial accumulated deficit and significant concerns about its ability to continue as a going concern.
CitroTech Inc. filed an amended 10-Q for the period ending June 30, 2026, detailing a significant revenue decrease and substantial net loss, while also highlighting ongoing efforts in product development and strategic partnerships.
NYSE
Yum China Holdings, Inc. announced robust financial results for the second quarter of 2026, demonstrating significant revenue and profit increases, alongside the strategic acquisition of the Pizza Hut brand in Mainland China.
NYSE
Berkshire Hathaway Inc. announced robust financial results for the second quarter and first six months of 2026, driven by strong performance across its diverse business segments, including insurance, railroads, utilities, and manufacturing.
NYSE
IONQ
Ionq, INCIonQ, Inc. (IONQ) reported a substantial increase in revenue for the second quarter of 2026, driven by hardware sales and acquisitions, but also disclosed significant net losses and increased operating expenses.
CitroTech Inc. (CITR) disclosed a substantial revenue decrease of 59% for the quarter ended June 30, 2026, alongside a net loss of $3.9 million, raising concerns about its financial stability.
NYSE
Affiliated Managers Group, Inc. (AMG) announced a substantial increase in assets under management and revenue for the second quarter of 2026, driven by strong performance across its diverse investment strategies.
BTS
The Goldman Sachs Physical Gold ETF experienced a notable decline in Net Asset Value per Share during the second quarter of 2026, primarily driven by a significant decrease in the price of gold.
NYSE
ManpowerGroup Inc. announced a significant increase in revenues and operating profit for the second quarter of 2026, driven by strong demand in the Americas and select European markets, alongside effective cost management.
NASDAQ
Creative Medical Technology Holdings, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing continued investment in R&D, strategic financing through warrant exercises, and progress in its regenerative medicine pipeline.
NASDAQ
Canary Staked SUI ETF (SUIS) reported a significant decrease in Net Asset Value (NAV) for the second quarter ended June 30, 2026, primarily driven by a substantial decline in the price of SUI.
AIxCrypto Holdings reported substantial net losses and significant cash burn, raising serious concerns about its ability to continue as a going concern, despite a strategic pivot towards AI and digital assets.
NASDAQ
Canary Marinade Solana ETF (SOLC) reported a decrease in Net Asset Value per Share to $14.71 as of June 30, 2026, driven by a significant decline in Solana's price.
NASDAQ
El Pollo Loco Holdings, Inc. announced its second-quarter 2026 financial results, showcasing a significant increase in total revenue and net income, driven by comparable restaurant sales growth and strategic initiatives.
NYSE
RYN
Rayonier INCRayonier Inc. (RYN) announced robust Q2 2026 results, driven by the integration of PotlatchDeltic, with significant sales and operating income increases across its timber and real estate segments.
NASDAQ
Cumberland Pharmaceuticals Inc. has completed a strategic transaction with Apotex, divesting its FDA-approved brands for $100 million to sharpen its focus on developing innovative product candidates.
NASDAQ
Collective Acquisition Corp. has extended its deadline to complete a business combination to August 8, 2027, while reporting net income driven by interest income on its trust account.
NASDAQ
Immix Biopharma's Q2 2026 10-Q filing details substantial capital raises, positive interim clinical trial data for NXC-201, and ongoing operational losses.
AMEX
Avalon Holdings Corporation's Q2 2026 filing shows a significant increase in net income compared to the prior year, driven by strong performance in its waste management services segment.
OQX
JANL
Janel CORPJanel Corporation's Q2 2026 Form 10-Q filing reveals significant revenue increases, primarily from its Logistics segment, bolstered by strategic acquisitions and improved operational efficiencies.
NASDAQ
Eightco Holdings Inc. reported a sharp 72.7% revenue decline in Q2 2026, significant operating losses, and a material weakness in internal controls, while digital asset fair value changes drove a net income of $17.7 million.
NASDAQ
Gyre Therapeutics, Inc. reported a net loss of $14.3 million for the second quarter of 2026, with revenues decreasing by 2% year-over-year, primarily due to a decline in collaboration revenue.
AMEX
Actinium Pharmaceuticals, Inc. announced its Q2 2026 financial results, highlighting a substantial increase in net income driven by the recognition of $35 million in deferred revenue from a prior licensing agreement.